Search details
1.
Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury.
Ann Neurol
; 2023 Aug 22.
Article
in English
| MEDLINE | ID: mdl-37606612
2.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-34914826
3.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38314663
4.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38400519
5.
Clinical and exercise professional opinion of return-to-running readiness after childbirth: an international Delphi study and consensus statement.
Br J Sports Med
; 58(6): 299-312, 2024 Mar 13.
Article
in English
| MEDLINE | ID: mdl-38148108
6.
Clinical and exercise professional opinion on designing a postpartum return-to-running training programme: an international Delphi study and consensus statement.
Br J Sports Med
; 58(4): 183-195, 2024 Feb 09.
Article
in English
| MEDLINE | ID: mdl-38191239
7.
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Blood
; 135(6): 449-452, 2020 02 06.
Article
in English
| MEDLINE | ID: mdl-31826244
8.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Article
in English
| MEDLINE | ID: mdl-33471943
9.
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
N Engl J Med
; 379(15): 1443-1451, 2018 10 11.
Article
in English
| MEDLINE | ID: mdl-30304652
10.
Chimeric antigen receptor T-cell therapy toxicities.
Br J Clin Pharmacol
; 87(6): 2414-2424, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32463929
11.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Article
in English
| MEDLINE | ID: mdl-32604096
12.
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Biol Blood Marrow Transplant
; 26(10): 1759-1769, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32623078
13.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32438043
14.
Reply to "Letter on Spasticity Predicts Motor Recovery in Motor Complete Spinal Cord Injury".
Ann Neurol
; 95(5): 1011-1012, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38501331
15.
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Blood
; 131(11): 1248-1257, 2018 03 15.
Article
in English
| MEDLINE | ID: mdl-29386198
16.
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 22(5): e13395, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32602954
17.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30826465
18.
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
Biol Blood Marrow Transplant
; 25(7): 1340-1346, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30763728
19.
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
Am J Hematol
; 94(12): 1382-1387, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31595538
20.
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.
Blood
; 128(10): 1346-61, 2016 09 08.
Article
in English
| MEDLINE | ID: mdl-27439912